Enhancing the Predictive Success of Complex In Vitro Models for Drug Discovery and Development
The 3D Tissue Models Summit is back in 2019 with world-leading experts to address the key challenges in the preclinical industry. Hear from the latest case studies to deepen your understanding of validation methods and technical advancements that are driving drug development and disease modeling.
Join 120+ industry stakeholders across the regulatory, pharmaceutical, biotech and academic landscape for effective cross-talk and interactive discussions. Discover how to apply the latest insight to enhance the predictive power of your therapeutic pipeline.
Session Track: Drug Discovery and Target Validation
Industry cross-talk between FDA, NIH and IQ consortia on how the latest partnerships are driving preclinical 3D guidelines towards scientific advancement.
Greater focus the latest validation techniques to enhance reproducibility and increase the therapeutic success of drug candidates.
Revealing insight into the latest imaging techniques incorporated into translational studies to improve disease modeling in cardiac, CNS, fibrosis models and many more.
Learn more at https://3d-tissuemodels.com/.